Hear more from our interview with Dr. Soff, where he shares more about his career in hematology, his myeloma diagnosis, and why Sergio Giralt, MD, is the only doctor allowed to perform his bone marrow biopsies.
Recent Articles
Pilot Study Finds Remote Monitoring of Patients Undergoing Chemotherapy Feasible
Using technology to monitor outpatients undergoing cancer treatments at home was feasible and led to improvements in care, according to results of a pilot...
Could APP-Led Quality and Safety Grand Rounds Improve Patient Outcomes?
Grand rounds provide an opportunity for oncology advanced practice providers (APPs) to discuss quality and safety across disciplines and may have positive effects on...
Classical Hematology: A Specialty in Decline?
As workforce shortages persist, this ancient art is undergoing a modern renaissance.
Two factors influenced Alfred Ian Lee, MD, PhD, to specialize in classical hematology....
Modified EASIX Score Predicts CRS and ICANS Before Severe Symptoms in Patients With B-Cell...
A modified version of the EASIX (Endothelial Activation and Stress Index) score, when calculated prior to and soon after chimeric antigen receptor (CAR) T-cell...
New Prognostic Model Outperforms Established Predictive Models in MDS
In a study published in the Journal of Clinical Oncology, researchers reported that a newly developed personalized prediction model comprising clinical and genomic data...
Current Issue
October 2021, Volume 7, Issue 12
This issue tells the long story of drug shortages, demystifies transfusion services, and more.